Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Originally published in Science Express on 19 May 2005
Science 17 June 2005:
Vol. 308. no. 5729, pp. 1777 - 1783
DOI: 10.1126/science.1112286
Prev | Table of Contents | Next

Reports

This article has been retracted

Patient-Specific Embryonic Stem Cells Derived from Human SCNT Blastocysts

Woo Suk Hwang,1,2* Sung Il Roh,3 Byeong Chun Lee,1 Sung Keun Kang,1 Dae Kee Kwon,1 Sue Kim,1 Sun Jong Kim,3 Sun Woo Park,1 Hee Sun Kwon,1 Chang Kyu Lee,2 Jung Bok Lee,3 Jin Mee Kim,3 Curie Ahn,4 Sun Ha Paek,4 Sang Sik Chang,5 Jung Jin Koo,5 Hyun Soo Yoon,6 Jung Hye Hwang,6 Youn Young Hwang,6 Ye Soo Park,6 Sun Kyung Oh,4 Hee Sun Kim,4 Jong Hyuk Park,7 Shin Yong Moon,4 Gerald Schatten7*

Patient-specific, immune-matched human embryonic stem cells (hESCs) are anticipated to be of great biomedical importance for studies of disease and development and to advance clinical deliberations regarding stem cell transplantation. Eleven hESC lines were established by somatic cell nuclear transfer (SCNT) of skin cells from patients with disease or injury into donated oocytes. These lines, nuclear transfer (NT)–hESCs, grown on human feeders from the same NT donor or from genetically unrelated individuals, were established at high rates, regardless of NT donor sex or age. NT-hESCs were pluripotent, chromosomally normal, and matched the NT patient's DNA. The major histocompatibility complex identity of each NT-hESC when compared to the patient's own showed immunological compatibility, which is important for eventual transplantation. With the generation of these NT-hESCs, evaluations of genetic and epigenetic stability can be made. Additional work remains to be done regarding the development of reliable directed differentiation and the elimination of remaining animal components. Before clinical use of these cells can occur, preclinical evidence is required to prove that transplantation of differentiated NT-hESCs can be safe, effective, and tolerated.

1 College of Veterinary Medicine, Seoul National University, Seoul 151-742, Korea.
2 School of Agricultural Biotechnology, Seoul National University, Seoul 151-742, Korea.
3 Medical Research Center, MizMedi Hospital, Seoul 135-280, Korea.
4 College of Medicine, Seoul National University, Seoul 110-744, Korea.
5 Hanna Women's Clinic, Seoul 137-872, Korea.
6 School of Medicine, Hanyang University, Seoul 471-701, Korea.
7 Pittsburgh Development Center, Magee-Womens Research Institute, Department of Obstetrics, Gynecology, and Reproductive Sciences and Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

* To whom correspondence should be addressed. E-mail: hwangws{at}snu.ac.kr (W.S.H.); gschatten{at}pdc.magee.edu (G.S.)

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Authorship: why not just toss a coin?.
K. Strange (2008)
Am J Physiol Cell Physiol 295, C567-C575
   Full Text »    PDF »
The road to pluripotence: the research response to the embryonic stem cell debate.
C. T. Scott and R. A. Reijo Pera (2008)
Hum. Mol. Genet. 17, R3-R9
   Abstract »    Full Text »    PDF »
Research ethics and lessons from Hwanggate: what can we learn from the Korean cloning fraud?.
R Saunders and J Savulescu (2008)
J. Med. Ethics 34, 214-221
   Abstract »    Full Text »    PDF »
From Revered to Reviled: A Cross-Cultural Narrative Analysis of the South Korean Cloning Scandal.
M. Kruvand and S. Hwang (2007)
Science Communication 29, 177-197
   Abstract »    PDF »
Hwang case review committee misses the mark.
M. Rossner (2007)
J. Cell Biol. 176, 131-132
   Full Text »    PDF »
Concise Review: Scientific and Ethical Roadblocks to Human Embryonic Stem Cell Therapy.
L. Gruen and L. Grabel (2006)
Stem Cells 24, 2162-2169
   Abstract »    Full Text »    PDF »
Correction of sickle cell disease by homologous recombination in embryonic stem cells.
L.-C. Wu, C.-W. Sun, T. M. Ryan, K. M. Pawlik, J. Ren, and T. M. Townes (2006)
Blood 108, 1183-1188
   Abstract »    Full Text »    PDF »
Embryonic Stem Cell-Derived Neuronally Committed Precursor Cells with Reduced Teratoma Formation After Transplantation into the Lesioned Adult Mouse Brain.
M. Dihne, C. Bernreuther, C. Hagel, K. O. Wesche, and M. Schachner (2006)
Stem Cells 24, 1458-1466
   Abstract »    Full Text »    PDF »
Role of Histone Acetylation in Reprogramming of Somatic Nuclei Following Nuclear Transfer.
A. Rybouchkin, Y. Kato, and Y. Tsunoda (2006)
Biol Reprod 74, 1083-1089
   Abstract »    Full Text »    PDF »
Stem Cell and Related Therapies: Nurses and midwives representing all parties.
S H Cedar (2006)
Nursing Ethics 13, 292-303
   Abstract »    PDF »
Why the apparent haste to clone humans?.
N Cobbe (2006)
J. Med. Ethics 32, 298-302
   Full Text »    PDF »
Science fraud: from patchwork mouse to patchwork data.
G. Weissmann (2006)
FASEB J 20, 587-590
   Full Text »    PDF »
Mirror exchange of donor gametes should also accommodate scientific research..
B. C. Heng and G. Q. Tong (2006)
Hum. Reprod. 21, 1100
   Full Text »    PDF »
Embryonic stem-cell gametes: the new frontier in human reproduction.
Z. Master (2006)
Hum. Reprod. 21, 857-863
   Abstract »    Full Text »    PDF »
Epigenetic Modification Is Central to Genome Reprogramming in Somatic Cell Nuclear Transfer.
L. Armstrong, M. Lako, W. Dean, and M. Stojkovic (2006)
Stem Cells 24, 805-814
   Abstract »    Full Text »    PDF »
Hematopoiesis from Human Embryonic Stem Cells: Overcoming the Immune Barrier in Stem Cell Therapies.
H. Priddle, D. R. E. Jones, P. W. Burridge, and R. Patient (2006)
Stem Cells 24, 815-824
   Abstract »    Full Text »    PDF »
How Many Human Embryonic Stem Cell Lines Are Sufficient? A U.S. Perspective.
C. I. Civin and M. S. Rao (2006)
Stem Cells 24, 800-803
   Full Text »    PDF »
Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells.
M. W. Lensch and G. Q. Daley (2006)
Blood 107, 2605-2612
   Abstract »    Full Text »    PDF »
Directed Differentiation of Human Embryonic Stem Cells into Functional Dendritic Cells through the Myeloid Pathway..
I. I. Slukvin, M. A. Vodyanik, J. A. Thomson, M. E. Gumenyuk, and K.-D. Choi (2006)
J. Immunol. 176, 2924-2932
   Abstract »    Full Text »    PDF »
Stromal Cell-Derived Inducing Activity, Nurr1, and Signaling Molecules Synergistically Induce Dopaminergic Neurons from Mouse Embryonic Stem Cells.
D.-W. Kim, S. Chung, M. Hwang, A. Ferree, H.-C. Tsai, J.-J. Park, S. Chung, T. S. Nam, U. J. Kang, O. Isacson, et al. (2006)
Stem Cells 24, 557-567
   Abstract »    Full Text »    PDF »
Designer blood: creating hematopoietic lineages from embryonic stem cells.
A. L. Olsen, D. L. Stachura, and M. J. Weiss (2006)
Blood 107, 1265-1275
   Abstract »    Full Text »    PDF »
Are journals doing enough to prevent fraudulent publication?.
(2006)
Can. Med. Assoc. J. 174, 431
   Full Text »    PDF »
Les journaux font-ils assez d'efforts pour prevenir la publication frauduleuse?.
(2006)
Can. Med. Assoc. J. 174, 433
   Full Text »    PDF »
Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders.
I. Mateizel, N. De Temmerman, U. Ullmann, G. Cauffman, K. Sermon, H. Van de Velde, M. De Rycke, E. Degreef, P. Devroey, I. Liebaers, et al. (2006)
Hum. Reprod. 21, 503-511
   Abstract »    Full Text »    PDF »
Beyond Fraud -- Stem-Cell Research Continues.
E. Y. Snyder and J. F. Loring (2006)
N. Engl. J. Med. 354, 321-324
   Full Text »    PDF »
Egg Donation and Human Embryonic Stem-Cell Research.
R. Steinbrook (2006)
N. Engl. J. Med. 354, 324-326
   Full Text »    PDF »
Korean cloning studies were fakes.
J. Parry (2006)
BMJ 332, 67
   Full Text »    PDF »
Korean stem cell pioneer resigns.
J. Parry (2006)
BMJ 332, 7
   Full Text »    PDF »
Temporal and parental-specific expression of imprinted genes in a newly derived Chinese human embryonic stem cell line and embryoid bodies.
B. W. Sun, A. C. Yang, Y. Feng, Y. J. Sun, Y. f. Zhu, Y. Zhang, H. Jiang, C. L. Li, F. R. Gao, Z. H. Zhang, et al. (2006)
Hum. Mol. Genet. 15, 65-75
   Abstract »    Full Text »    PDF »
Human Embryonic Stem Cells Reprogram Myeloid Precursors Following Cell-Cell Fusion.
J. Yu, M. A. Vodyanik, P. He, I. I. Slukvin, and J. A. Thomson (2006)
Stem Cells 24, 168-176
   Abstract »    Full Text »    PDF »
Engineering Myocardial Tissue.
T. Eschenhagen and W. H. Zimmermann (2005)
Circ. Res. 97, 1220-1231
   Abstract »    Full Text »    PDF »
Global gene expression profiles reveal significant nuclear reprogramming by the blastocyst stage after cloning.
S. L. Smith, R. E. Everts, X. C. Tian, F. Du, L.-Y. Sung, S. L. Rodriguez-Zas, B.-S. Jeong, J.-P. Renard, H. A. Lewin, and X. Yang (2005)
PNAS 102, 17582-17587
   Abstract »    Full Text »    PDF »
A New Era in the Ethics of Human Embryonic Stem Cell Research.
B. Lo, P. Zettler, M. I. Cedars, E. Gates, A. R. Kriegstein, M. Oberman, R. Reijo Pera, R. M. Wagner, M. T. Wuerth, L. E. Wolf, et al. (2005)
Stem Cells 23, 1454-1459
   Abstract »    Full Text »    PDF »
Stem Cell Research: Paths to Cancer Therapies and Regenerative Medicine.
I. Weissman (2005)
JAMA 294, 1359-1366
   Abstract »    Full Text »    PDF »
The CMA Code of Ethics and the donation of fresh embryos for stem cell research.
J. Nisker and A. White (2005)
Can. Med. Assoc. J. 173, 621-622
   Full Text »    PDF »
Methods for Derivation of Human Embryonic Stem Cells.
H. S. Kim, S. K. Oh, Y. B. Park, H. J. Ahn, K. C. Sung, M. J. Kang, L. A. Lee, C. S. Suh, S. H. Kim, D.-W. Kim, et al. (2005)
Stem Cells 23, 1228-1233
   Abstract »    Full Text »    PDF »
Nuclear Reprogramming of Somatic Cells After Fusion with Human Embryonic Stem Cells.
C. A. Cowan, J. Atienza, D. A. Melton, and K. Eggan (2005)
Science 309, 1369-1373
   Abstract »    Full Text »    PDF »
In brief.
(2005)
BMJ 330, 1346
   Full Text »    PDF »
UK and Korean teams refine techniques for human cloning.
S. Mayor (2005)
BMJ 330, 1225
   Full Text »    PDF »

E-Letters:

Read all E-Letters

Egg-sharing to alleviate the shortage of donor oocytes for therapeutic cloning
Boon C. Heng, et al.
Science Online, 24 May 2005 [Full text]

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)